Agenda-setting intelligence, analysis and advice for the global fashion community.
The author has shared a Podcast.You will need to accept and consent to the use of cookies and similar technologies by our third-party partners (including: YouTube, Instagram or Twitter), in order to view embedded content in this article and others you may visit in future.
Listen to and follow “The Debrief”: Apple Podcasts | Spotify | Overcast
Background:
Beauty has long been one of the industry’s most reliable growth engines — fragrance boomed post-pandemic, prestige beauty held up better than other categories, and value-driven brands like E.l.f. proved that sharp pricing and marketing could keep consumers spending. But a slowdown that began last year and has only become more pronounced since has challenged that thinking.
In this episode, senior correspondent Sheena Butler-Young is joined by BoF senior beauty correspondent Daniela Morosini to unpack the first half’s earnings across the beauty conglomerates — from Estée Lauder and Shiseido to L’Oréal, Beiersdorf and E.l.f. — and identify what’s still driving growth and what’s stalling, as well as what investors will be watching for next.
Key Insights:
- Selective Spending, Not Shrinking Wallets: Consumers haven’t stopped buying beauty — they’ve become pickier about where they spend and what they’re purchasing. “People are just getting a little bit more selective,” said Morosini. Shopping itself is shifting, too: “Maybe it’s not always Sephora and Ulta. Maybe it’s TikTok Shop.”
- Skincare Results, Injectables and the Price-Value Equation: Affordable, results-driven skincare brands are outperforming, while medical aesthetics are surging in parallel. Morosini points specifically to “the derm-backed skincare brands or the dermatological brands, the more affordable ones like CeraVe and La Roche-Posay, alongside the growing pull of the lasers and the injectables.”
- Hair’s Unexpected Boom: Hair has emerged as one of the biggest bright spots this earnings season, driven equally by innovation and a cultural shift around hair loss. Morosini notes, “hair loss has just become so much more of a hot topic and I think a lot of stigma has been removed,” while also crediting brands like K18 and Olaplex that “have increased what we expect hair products to do for us.”
- Estée Lauder’s Momentum Question: Lauder posted a 17 percent stock jump on its first results under new leadership, but Morosini cautions the win may be borrowed. “The question is how much has Estée Lauder improved its brand’s desirability and how much has it benefited from a rising tide,” she says, adding that stripped of Amazon Prime Day effects, US growth was closer to “about two percent.”
- The Danger of the One-Hero Brand: From E.l.f.’s reliance on Rhode to Beiersdorf’s dependence on Nivea, this earnings season exposed how a single hero product can mask underlying weakness. “When that’s basically all concentrated around one brand, that makes investors a little bit nervous,” Morosini says, noting the read-through for M&A: “At a certain point you have to buy the growth.”
